Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery

[1]  Corneel Coens,et al.  Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials , 2018, Cancer.

[2]  M. Groenvold,et al.  Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol , 2018, BMJ Open.

[3]  P. Neven,et al.  The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer. , 2017, Journal of geriatric oncology.

[4]  Chung-Ying Lin,et al.  Development of diabetes-specific quality of life module to be in conjunction with the World Health Organization quality of life scale brief version (WHOQOL-BREF) , 2017, Health and Quality of Life Outcomes.

[5]  M. Sprangers,et al.  Structural equation modeling-based effect-size indices were used to evaluate and interpret the impact of response shift effects. , 2017, Journal of clinical epidemiology.

[6]  F. Guillemin,et al.  Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time , 2016, Health and Quality of Life Outcomes.

[7]  A. Hinke,et al.  Quality of life in patients with metastatic colorectal cancer receiving maintenance therapy after first-line inductive treatment: A quality of life sub-analysis of the AIO KRK 0207 phase III trial , 2016 .

[8]  Charles Taft,et al.  Minimal important differences for fatigue patient reported outcome measures—a systematic review , 2016, BMC Medical Research Methodology.

[9]  M. Taphoorn,et al.  The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative. , 2016, Journal of the National Cancer Institute.

[10]  F. Fiteni,et al.  Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review , 2016, BMC Cancer.

[11]  H. Wildiers,et al.  International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Liying Zhang,et al.  Minimal important differences in the EORTC QLQ‐C30 in patients with advanced cancer , 2014, Asia-Pacific journal of clinical oncology.

[13]  J. Browne,et al.  The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research , 2014, BMJ quality & safety.

[14]  F. Guillemin,et al.  Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients , 2012, Health and Quality of Life Outcomes.

[15]  Alexis Wright,et al.  Clinimetrics corner: a closer look at the minimal clinically important difference (MCID) , 2012, The Journal of manual & manipulative therapy.

[16]  Liying Zhang,et al.  Meaningful change in oncology quality-of-life instruments: a systematic literature review , 2012, Expert review of pharmacoeconomics & outcomes research.

[17]  P. Fayers,et al.  Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2012, European journal of cancer.

[18]  M. King.  A point of minimal important difference (MID): a critique of terminology and methods , 2011, Expert review of pharmacoeconomics & outcomes research.

[19]  Magdalena Szumilas.  Explaining odds ratios. , 2010, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

[20]  C. Terwee,et al.  Mind the MIC: large variation among populations and methods. , 2010, Journal of clinical epidemiology.

[21]  R. Tashjian,et al.  Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease. , 2009, Journal of shoulder and elbow surgery.

[22]  R. Kane.  The clinical significance of statistical significance. , 2008, The oncologist.

[23]  R. Hays,et al.  Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. , 2008, Journal of clinical epidemiology.

[24]  D. Redelmeier,et al.  Interpreting clinically significant changes in patient‐reported outcomes , 2007, Cancer.

[25]  B. Röhrig,et al.  Co-morbidity and functional deficits independently contribute to quality of life before chemotherapy in elderly cancer patients , 2007, Supportive Care in Cancer.

[26]  Fritz Drasgow,et al.  Polychoric and Polyserial Correlations , 2006 .

[27]  D. Neuberg,et al.  A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. , 2004, Journal of clinical epidemiology.

[28]  R. Westendorp,et al.  The 15‐item Geriatric Depression Scale (GDS‐15) detects changes in depressive symptoms after a major negative life event. The Leiden 85‐plus Study , 2004, International journal of geriatric psychiatry.

[29]  M. Jensen,et al.  Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. , 2003, The journal of pain : official journal of the American Pain Society.

[30]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[31]  D. Cella,et al.  Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. , 2002, Journal of pain and symptom management.

[32]  G. Samsa,et al.  Determining Clinically Important Differences in Health Status Measures , 1999, PharmacoEconomics.

[33]  P J Garry,et al.  The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. , 1999, Nutrition.

[34]  M. King.  The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 , 1996, Quality of Life Research.

[35]  S. Fosså,et al.  Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .

[37]  Sydney Katz.  Assessing Self‐maintenance: Activities of Daily Living, Mobility, and Instrumental Activities of Daily Living , 1983, Journal of the American Geriatrics Society.

[38]  Scott E. Maxwell,et al.  Internal Invalidity in Pretest-Posttest Self-Report Evaluations and a Re-evaluation of Retrospective Pretests , 1979 .

[39]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[40]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[41]  M. Sprangers,et al.  An application of structural equation modeling to detect response shifts and true change in quality of life data from cancer patients undergoing invasive surgery , 2005, Quality of Life Research.

[42]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.